Source: Annual Congress 2001 - Diseases of the airways including SAS
Disease area: Airway diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
C. R. Canova, J. D. Leuppi, S. H. Downs, M. Andersson, N. Kuenzli, A. Knoblauch (Basle, St. Gallen, Switzerland; Lund, Sweden). Perennial allergies in patients treated with nCPAP for obstructive sleep apnoea. Eur Respir J 2001; 16: Suppl. 31, 1506

Member's Comments

No comment yet.

Related content which might interest you: Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma Source: Annual Congress 2011 - Asthma: risk factors and comorbidities Year: 2011 Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Non-CPAP therapies in obstructive sleep apnoea Source: Guideline 2011 Year: 2011 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002 Associated pathologies and tobacco habit in patients diagnosed of obstructive sleep apnoea syndrome treated with nCPAP Source: Eur Respir J 2002; 20: Suppl. 38, 451s Year: 2002 Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 The prevalance of bronchial hyperreactivity in patients with habitual snoring and obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 495s Year: 2002 Long-term CPAP compliance in women with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 The role of bi-level therapy in obstructive sleep apnoea Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008 Effect of obstructive sleep apnea on asthma control Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 The frequency of rhinitis in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 410s Year: 2006 Effects of long term nCPAP treatment on patients with obstructive sleep apnoea syndrom Source: Eur Respir J 2007; 30: Suppl. 51, 322s Year: 2007